13F Data
13F filer · CIK 1224962

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$6.7B
+$1.5B vs prior
Positions
109
New / sold out
29 / 14
Added / reduced
30 / 26
Turnover
18.1%
buys $1.6B · sells $1.1B
Top-10 weight
47.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA A/S+1,163,721–+$310.4M
NewKARDIGAN INC+8,200,662–+$195.6M
NewAVALYN PHARMACEUTICALS INC+2,675,296–+$88.1M
AddedRELAY THERAPEUTICS INC+4,355,046+44.7%+$81.5M
AddedTANGO THERAPEUTICS INC+2,568,847+317.9%+$80.3M
NewBIOGEN INC+276,173–+$59.7M
AddedREVOLUTION MEDICINES INC+269,000+104.0%+$50.4M
NewUNITEDHEALTH GROUP INC+116,806–+$48.5M
AddedSPYRE THERAPEUTICS INC+536,271+14.2%+$47.6M
NewSPDR SERIES TRUSTPUT+300,000–+$47.5M
49 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outASCENDIS PHARMA A/S-1,531,421-100.0%$-350.3M
Sold outCENTESSA PHARMACEUTICALS PLC-5,258,903-100.0%$-208.9M
ReducedDYNE THERAPEUTICS INC-1,979,604-42.4%$-44.0M
Sold outENGENE HOLDINGS INC-5,827,506-100.0%$-39.7M
ReducedGUARDANT HEALTH INC-258,673-86.2%$-38.8M
Sold outDAY ONE BIOPHARMACEUTICALS I-1,755,799-100.0%$-37.6M
ReducedABIVAX SA-254,884-77.5%$-34.0M
ReducedAPOGEE THERAPEUTICS INC-232,271-15.1%$-30.8M
ReducedPROTAGONIST THERAPEUTICS INC-249,000-20.2%$-30.5M
Sold outBRIGHT MINDS BIOSCIENCES INC-377,544-100.0%$-27.5M
30 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $991.7MQ3 2013: $1.2BQ4 2013: $832.6MQ1 2014: $951.7MQ2 2014: $1.0BQ3 2014: $988.0MQ4 2014: $1.2BQ1 2015: $1.3BQ2 2015: $1.7BQ3 2015: $2.5BQ4 2015: $1.4BQ1 2016: $1.1BQ2 2016: $1.4BQ3 2016: $1.5BQ4 2016: $1.4BQ1 2017: $1.8BQ2 2017: $2.0BQ3 2017: $2.6BQ4 2017: $3.0BQ1 2018: $3.6BQ2 2018: $3.8BQ3 2018: $3.7BQ4 2018: $2.6BQ1 2019: $3.5BQ2 2019: $4.4BQ3 2019: $3.8BQ4 2019: $5.1BQ1 2020: $3.8BQ2 2020: $6.2BQ3 2020: $6.8BQ4 2020: $9.3BQ1 2021: $7.9BQ2 2021: $15.4BQ3 2021: $6.9BQ4 2021: $13.0BQ1 2022: $4.8BQ2 2022: $3.2BQ3 2022: $3.4BQ4 2022: $3.6BQ1 2023: $3.4BQ2 2023: $3.5BQ3 2023: $3.0BQ4 2023: $4.6BQ1 2024: $5.7BQ2 2024: $4.2BQ3 2024: $4.7BQ4 2024: $3.6BQ1 2025: $2.8BQ2 2025: $2.7BQ3 2025: $3.5BQ4 2025: $5.6BQ1 2026: $5.1BQ2 2026: $6.7B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PRAXIS PRECISION MEDICINES ICOM NEW2,035,986$681.6M10.23%
2SPYRE THERAPEUTICS INCCOM NEW4,319,496$383.5M5.76%
3CELCUITY INCCOM3,197,200$334.5M5.02%
4ASCENDIS PHARMA A/SORD SHS1,163,721$310.4M4.66%
5RHYTHM PHARMACEUTICALS INCCOM2,586,295$287.2M4.31%
6ROIVANT SCIENCES LTDSHS8,085,461$286.1M4.30%
7RELAY THERAPEUTICS INCCOM14,106,187$263.9M3.96%
8TRAVERE THERAPEUTICS INCCOM3,752,574$213.2M3.20%
9KARDIGAN INCCOM8,200,662$195.6M2.94%
10NUVALENT INCCOM1,580,505$195.2M2.93%
99 more rows. Subscribe for $29/month to see every row, download the data and use the API.